Skip to main content
. 2018 Nov 19;13:7623–7631. doi: 10.2147/IJN.S179226

Figure 6.

Figure 6

In vivo 5637 cells xenograft inhibition analysis.

Notes: Relative tumor volume (A) and survival percentage (B) after different treatments at day 0 with DOX and/or ZnPC was administrated at a total dose of 20 mg/kg body weight (n=6, **P<0.01).

Abbreviations: DOX, doxorubicin; TNP, thermal-responsive nanoparticle; ZnPC, zinc phthalocyanine.